Innovation in the life sciences finance function
As we edge towards the third decade of the century, business as usual is no longer sufficient to keep up with the pace of innovation and unprecedented changes in the life sciences industry. Amid continuous disruption, the life sciences CFO has an opportunity to take the reins.
Leading CFOs are focusing on leveraging disruption into opportunities to gain a competitive advantage and grow, while also improving their current operations. Experience shows that CFOs are deriving significant benefits for their organisations by focusing on the following key areas:
Life sciences CFOs need to take steps to disrupt their finance functions or face a drain on talent and the abilities to grow revenue and deploy capital effectively. One of the keys to success is creating a blueprint for how the finance organisation can turn disruptions into opportunity.
© 2019 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.KPMG International Cooperative (“KPMG International”) is a Swiss entity.
Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.